Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (4): 811-813. doi: 10.19723/j.issn.1671-167X.2021.04.033

Previous Articles     Next Articles

Bilateral papillary renal cell carcinoma following kidney transplantation: A case report

HONG Peng1,TIAN Xiao-jun1,ZHAO Xiao-yu1,YANG Fei-long1,LIU Zhuo1,LU Min2,ZHAO Lei1,Δ(),MA Lu-lin1,Δ()   

  1. 1. Department of Urology, Peking University Third Hospital, Beijing 100191, China
    2. Department of Pathology, Peking University Third Hospital, Beijing 100191, China
  • Received:2021-03-14 Online:2021-08-18 Published:2021-08-25
  • Contact: Lei ZHAO,Lu-lin MA E-mail:bysyzhaolei@163.com;malulin@medmail.com.cn
  • Supported by:
    Key Clinical Projects of Peking University Third Hospital(BYSYZD2019032)

RICH HTML

 10   

PDF (PC)

76

Abstract:

With the continuous development of kidney transplantation technique, the survival time after kidney transplantation is gradually prolonged. Thus, the malignant tumor has been the important influencing factor on the long-term survival for kidney transplantation patients. Renal cell carcinoma is a relatively common tumor after kidney transplantation. Besides, clear cell renal cell carcinoma and papillary renal cell carcinoma are the relatively common pathological types for renal cell carcinoma following kidney transplantation. However, bilateral renal cell carcinoma following kidney transplantation is comparatively rare. In this article, we presented a case of bilateral papillary renal cell carcinoma, which occurred after kidney transplantation. And the diagnosis and treatment were introduced in detail. The patient was 37 years old, and he underwent kidney transplantation 13 years ago in our hospital, because of kidney failure. After kidney transplantation, he had regular medical check-up every year. In this year, his urological ultrasound results indicated bilateral renal tumors. And then, he received abdominal and pelvic computed tomography, and the result also showed bilateral renal tumors, which were likely to be malignant tumors. After adequate consultation, the patient chose surgical treatment. The patient received long-term immunosuppressive therapy, because of kidney transplantation. Considering this, the surgeon decided to choose a staging surgical treatment, in order to reduce the bad influence of one-stage surgery. Then, the patient first underwent retroperitoneal laparoscopic radical nephrectomy for right renal tumor in our hospital, and he had no complications after operation. The pathological results showed papillary renal cell carcinoma. He was discharged successfully. He underwent retroperitoneal laparoscopic radical nephrectomy for left renal tumor in our hospital one month later, and he had no complications after operation. The pathological results also showed papillary renal cell carcinoma. He was discharged successfully two days after surgery. In the 3-month follow-up, the patient was recovering well. To sum up, the incidence of bilateral renal cell carcinoma following kidney transplantation is relatively rare, and bilateral radical nephrectomy is effective and safe treatment. Above all, it is the patient’s condition that determines the choice of staging surgery or simultaneous surgery.

Key words: Kidney transplantation, Bilateral renal cell carcinoma, Papillary renal cell carcinoma, Surgical treatment

CLC Number: 

  • R737.11

Figure 1

CT of bilateral renal cell carcinoma"

[1] Briggs JD. Causes of death after renal transplantation [J]. Nephrol Dial Transplant, 2001, 16(8):1545-1549.
doi: 10.1093/ndt/16.8.1545
[2] Végso G, Tóth M, Hídvégi M, et al. Malignancies after renal transplantation during 33 years at a single center [J]. Pathol Oncol Res, 2007, 13(1):63-69.
doi: 10.1007/BF02893443
[3] Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States [J]. Am J Transplant, 2004, 4(6):905-913.
doi: 10.1111/ajt.2004.4.issue-6
[4] Collett D, Mumford L, Banner NR, et al. Comparison of the incidence of malignancy in recipients of different types of organ: a UK registry audit [J]. Am J Transplant, 2010, 10(8):1889-1896.
doi: 10.1111/j.1600-6143.2010.03181.x pmid: 20659094
[5] Engels EA, Pfeiffer RM, Fraumeni JF, et al. Spectrum of cancer risk among US solid organ transplant recipients [J]. JAMA, 2011, 306(17):1891-1901.
doi: 10.1001/jama.2011.1592 pmid: 22045767
[6] 张健, 马麟麟, 解泽林, 等. 我国肾移植术后新发恶性肿瘤总结分析 [J]. 中华器官移植杂志, 2014, 35(12):705-710.
[7] Karami S, Yanik EL, Moore LE, et al. Risk of renal cell carcinoma among kidney transplant recipients in the United States [J]. Am J Transplant, 2016, 16(12):3479-3489.
doi: 10.1111/ajt.13862 pmid: 27160653
[8] Apel H, Walschburger-Zorn K, Häberle L, et al. De novo malignancies in renal transplant recipients: experience at a single center with 1 882 transplant patients over 39 yr [J]. Clin Transplant, 2013, 27(1):E30-E36.
doi: 10.1111/ctr.2013.27.issue-1
[9] Choyke PL. Acquired cystic kidney disease [J]. Eur Radiol, 2000, 10(12):1716-1721.
doi: 10.1007/s003300000601
[10] Hoshida Y, Nakanishi H, Shin M, et al. Renal neoplasias in patients receiving dialysis and renal transplantation: clinico-pathological features and p53 gene mutations [J]. Transplantation, 1999, 68(3):385-390.
pmid: 10459542
[11] Leveridge M, Musquera M, Evans A, et al. Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients [J]. J Urol, 2011, 186(1):219-223.
doi: 10.1016/j.juro.2011.03.032 pmid: 21575970
[12] Ishikawa I, Honda R, Yamada Y, et al. Renal cell carcinoma detected by screening shows better patient survival than that detected following symptoms in dialysis patients [J]. Ther Apher Dial, 2004, 8(6):468-473.
pmid: 15663546
[13] Klatte T, Seitz C, Waldert M, et al. Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients [J]. BJU Int, 2010, 105(9):1260-1265.
doi: 10.1111/bju.2010.105.issue-9
[14] Gigante M, Neuzillet Y, Patard JJ, et al. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities [J]. BJU Int, 2012, 110(11Pt B):E570-E573.
doi: 10.1111/bju.2012.110.issue-11b
[15] Wang B, Gong H, Zhang X, et al. Bilatetal synchronous sporadic renal cell carcinoma: retroperitoneoscopic strategies and intermediate outcomes of 60 patients [J]. PLoS One, 2016, 11(5):e154578.
[16] Rothman J, Crispen PL, Wong YN, et al. Pathologic concordance of sporadic synchronous bilateral renal mases [J]. Urology, 2008, 72(1):138-142.
doi: 10.1016/j.urology.2008.01.043 pmid: 18336882
[17] Becker F, Siemer S, Tzavaras A, et al. Long-term survival in bilateral renal cell carcinoma: a retrospective single-institutional analysis of 101 patients after surgical treatment [J]. Urology, 2008, 72(2):349-353.
doi: 10.1016/j.urology.2008.04.001 pmid: 18485459
[18] Lowrance WT, Yee DS, Maschino AC, et al. Developments in the surgical management of sporadic synchronous bilateral renal tumours [J]. BJU Int, 2010, 105(8):1093-1097.
doi: 10.1111/j.1464-410X.2009.08844.x pmid: 19751262
[1] Qiu-yu LI,Qin CHENG,Zhi-ling ZHAO,Ni-ni DAI,Lin ZENG,Lan ZHU,Wei GUO,Chao LI,Jun-hong WANG,Shu LI,Qing-gang GE,Ning SHEN. Severe acute respiratory syndrome coronavirus 2 infection in renal transplant recipients: A case report [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 780-784.
[2] Jie YANG,Ran ZHANG,Yu-nan LIU,Dian-can WANG. Plunging ranula presenting as a giant retroauricular mass: A case report [J]. Journal of Peking University(Health Sciences), 2020, 52(1): 193-195.
[3] Kai MA,Xing-ke QU,Qing-quan XU,Liu-lin XIONG,Xiong-jun YE,Li-zhe AN,Wei-nan CHEN,Xiao-bo HUANG. Endoscopic treatment for ureterovesical junction stenosis in patients with kidney transplantation: 13 cases report [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1155-1158.
[4] Rong YANG,Qing-xiang LI,Chi MAO,Xin PENG,Yang WANG,Yu-xing GUO,Chuan-bin GUO. Multimodal image fusion technology for diagnosis and treatment of the skull base-infratemporal tumors [J]. Journal of Peking University(Health Sciences), 2019, 51(1): 53-58.
[5] DING Zhen-shan，QIU Min，XU Zi-cheng，XIAO Ruo-tao，GE Li-yuan，MA Lu-lin. Clinicopathological analysis of patients with papillary renal cell carcinoma complicated by tumor thrombus [J]. Journal of Peking University(Health Sciences), 2018, 50(5): 805-810.
[6] ZHAO Lei, MA Lu-lin, ZHANG Hong-xian, HOU Xiao-fei, LIU Lei, FU Yan, KOU Yun-geng, SONG Yi-meng. Technical improvement in retroperitoneal laparoscopic living donor nephrectomy: report of 193 cases [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 867-871.
[7] ZHANG Hong-xian, ZHAO Lei, MA Lu-lin, HOU Xiao-fei, LIU Lei, DENG Shao-hui. Retroperitoneal laparoscopic nephrectomy with autotransplantation for severe iatrogenic ureteral injury [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 622-626.
[8] LIU Yu-Qing, LU Jian, ZHAO Lei, HOU Xiao-Fei, MA Lu-Lin. Prognostic factors for intravesical recurrence after surgery for upper tract urothelial carcinoma in renal transplant recipients [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 605-610.
[9] LIU Lei, MA Lu-Lin, ZHAO Lei, ZHANG Hong-Xian, HOU Xiao-Fei. Ureteral stricture following renal transplantation: risk factors and surgical management [J]. Journal of Peking University(Health Sciences), 2014, 46(4): 548-551.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2009, 41(6): 682 -686 .
[6] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd